Molecular and bioenergetic differences between cells with African versus European inherited mitochondrial DNA haplogroups: implications for population susceptibility to diseases.
暂无分享,去创建一个
M. Vawter | A. Nesburn | D. Wallace | S. Jazwinski | B. Kuppermann | M. C. Kenney | M. Chwa | Shari R Atilano | P. Falatoonzadeh | Claudio Ramírez | Deepika Malik | M. Tarek | Javier Cáceres Del Carpio | D. Boyer | M. Miceli | N. Udar | Douglas C. Wallace | Javier Cáceres del Carpio
[1] D. Scharnweber,et al. Sulfated glycosaminoglycans as promising artificial extracellular matrix components to improve the regeneration of tissues. , 2013, Current medicinal chemistry.
[2] M. Soma,et al. Complement‐mediated chronic inflammation is associated with diabetic microvascular complication , 2013, Diabetes/metabolism research and reviews.
[3] S. Ikegawa,et al. Human Genetic Disorders Caused by Mutations in Genes Encoding Biosynthetic Enzymes for Sulfated Glycosaminoglycans* , 2013, The Journal of Biological Chemistry.
[4] Jun Liu,et al. Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004. , 2013, Arthritis and rheumatism.
[5] E. Puffenberger,et al. Severity of cardiomyopathy associated with adenine nucleotide translocator-1 deficiency correlates with mtDNA haplogroup , 2013, Proceedings of the National Academy of Sciences.
[6] A. Nesburn,et al. Mitochondrial DNA Variants Mediate Energy Production and Expression Levels for CFH, C3 and EFEMP1 Genes: Implications for Age-Related Macular Degeneration , 2013, PloS one.
[7] K. Wiley,et al. Ethnic Differences in DNA Methyltransferases Expression in Patients with Systemic Lupus Erythematosus , 2012, Journal of Clinical Immunology.
[8] M. Marazita,et al. Interaction between IRF6 and TGFA Genes Contribute to the Risk of Nonsyndromic Cleft Lip/Palate , 2012, PloS one.
[9] M. Tuszynski,et al. JNK3 Perpetuates Metabolic Stress Induced by Aβ Peptides , 2012, Neuron.
[10] G. Alarcón,et al. Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population. , 2012, Arthritis and rheumatism.
[11] E. Ruiz-Pesini,et al. Oxidative phosphorylation differences between mitochondrial DNA haplogroups modify the risk of Leber's hereditary optic neuropathy. , 2012, Biochimica et biophysica acta.
[12] F. Liew,et al. Interleukin-33 and the function of innate lymphoid cells. , 2012, Trends in immunology.
[13] T. Laveist,et al. Racial/Ethnic Disparities in the Prevalence of Selected Chronic Diseases Among US Air Force Members, 2008 , 2012, Preventing chronic disease.
[14] S. John,et al. JNK2 and JNK3 are major regulators of axonal injury-induced retinal ganglion cell death , 2012, Neurobiology of Disease.
[15] Hsiao-Wen Chen,et al. A mitochondrial etiology of Alzheimer and Parkinson disease. , 2012, Biochimica et biophysica acta.
[16] F. Liew,et al. IL-33: a Janus cytokine , 2012, Annals of the rheumatic diseases.
[17] N. Oreiro,et al. Mitochondrial Haplogroups Define Two Phenotypes of Osteoarthritis , 2012, Front. Physio..
[18] N. Arsenijević,et al. IL-33/ST2 axis in inflammation and immunopathology , 2012, Immunologic research.
[19] V. Yong,et al. Chondroitin sulphate proteoglycans: extracellular matrix proteins that regulate immunity of the central nervous system. , 2011, Autoimmunity reviews.
[20] M. Schmitz,et al. The Dual Function Cytokine IL-33 Interacts with the Transcription Factor NF-κB To Dampen NF-κB–Stimulated Gene Transcription , 2011, The Journal of Immunology.
[21] K. Ohno-Matsui. Parallel findings in age-related macular degeneration and Alzheimer’s disease , 2011, Progress in Retinal and Eye Research.
[22] R. Testa,et al. Mitochondrial DNA Backgrounds Might Modulate Diabetes Complications Rather than T2DM as a Whole , 2011, PloS one.
[23] Wei Zhang,et al. Human proteins with affinity for dermatan sulfate have the propensity to become autoantigens. , 2011, The American journal of pathology.
[24] A. Czarnecka,et al. The Role of the Mitochondrial Genome in Ageing and Carcinogenesis , 2011, Journal of aging research.
[25] M. Hauptmann,et al. Ligands of Epidermal Growth Factor Receptor and the Insulin-Like Growth Factor Family as Serum Biomarkers for Response to Epidermal Growth Factor Receptor Inhibitors in Patients with Advanced Non-small Cell Lung Cancer , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[26] Manuela G. López,et al. Antioxidant, antiinflammatory and neuroprotective actions of chondroitin sulfate and proteoglycans. , 2010, Osteoarthritis and cartilage.
[27] P. du Souich,et al. Modulation of inflammation by chondroitin sulfate. , 2010, Osteoarthritis and cartilage.
[28] C. Januário,et al. Mitochondrial-dependent apoptosis in Huntington's disease human cybrids , 2010, Experimental Neurology.
[29] R. Gold,et al. Mitochondrial haplogroup H correlates with ATP levels and age at onset in Huntington disease , 2010, Journal of Molecular Medicine.
[30] B. Vainer,et al. IL-33 is upregulated in colonocytes of ulcerative colitis. , 2010, Immunology letters.
[31] I. McInnes,et al. Role of interleukin 33 in human immunopathology , 2009, Annals of the rheumatic diseases.
[32] I. McInnes,et al. IL-33 Amplifies the Polarization of Alternatively Activated Macrophages That Contribute to Airway Inflammation1 , 2009, The Journal of Immunology.
[33] K. Langa,et al. Cognitive performance and informant reports in the diagnosis of cognitive impairment and dementia in African Americans and whites , 2009, Alzheimer's & Dementia.
[34] J. Moreno-Navarrete,et al. Complement Factor H Is Expressed in Adipose Tissue in Association With Insulin Resistance , 2009, Diabetes.
[35] L. Rönnblom,et al. C1q inhibits immune complex-induced interferon-alpha production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis. , 2009, Arthritis and rheumatism.
[36] J. Beckmann,et al. JNK3 is abundant in insulin-secreting cells and protects against cytokine-induced apoptosis , 2009, Diabetologia.
[37] P. du Souich,et al. Immunomodulatory and anti-inflammatory effects of chondroitin sulphate , 2009, Journal of cellular and molecular medicine.
[38] J. Langberg,et al. Mitochondrial DNA haplogroups associated with age-related macular degeneration. , 2009, Investigative ophthalmology & visual science.
[39] H. Kita,et al. IL-33-activated dendritic cells induce an atypical TH2-type response. , 2009, The Journal of allergy and clinical immunology.
[40] D. Taverna,et al. Mitochondrial DNA variability modulates mRNA and intra-mitochondrial protein levels of HSP60 and HSP75: experimental evidence from cybrid lines , 2009, Cell Stress and Chaperones.
[41] D. Turnbull,et al. Batteries not included: diagnosis and management of mitochondrial disease , 2009, Journal of internal medicine.
[42] J. Pollheimer,et al. Vascular Biology , Atherosclerosis and Endothelium Biology Nuclear Interleukin-33 Is Generally Expressed in Resting Endothelium but Rapidly Lost upon Angiogenic or Proinflammatory Activation , 2010 .
[43] Dirk E. Smith,et al. IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. , 2008, International immunology.
[44] S. Campo,et al. Purified human plasma glycosaminoglycans reduced NF-κB activation, pro-inflammatory cytokine production and apoptosis in LPS-treated chondrocytes , 2008, Innate immunity.
[45] J. Manly,et al. Diagnosis and assessment of Alzheimer's disease in diverse populations , 2008, Alzheimer's & Dementia.
[46] Ashley M. Miller,et al. IL-33 reduces the development of atherosclerosis , 2008, The Journal of experimental medicine.
[47] I. McInnes,et al. IL‐33 is a chemoattractant for human Th2 cells , 2007, European journal of immunology.
[48] M. Peek,et al. Diabetes Health Disparities , 2007, Medical care research and review : MCRR.
[49] Patrick F Chinnery,et al. Clinical expression of Leber hereditary optic neuropathy is affected by the mitochondrial DNA-haplogroup background. , 2007, American journal of human genetics.
[50] Delphine A. Lacorre,et al. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo , 2007, Proceedings of the National Academy of Sciences.
[51] C. Franceschi,et al. Gene expression of cytokines and cytokine receptors is modulated by the common variability of the mitochondrial DNA in cybrid cell lines , 2006, Genes to cells : devoted to molecular & cellular mechanisms.
[52] A. R. Vieira,et al. Human Genome Epidemiology (HuGE) Review Association between the Transforming Growth Factor Alpha Gene and Nonsyndromic Oral Clefts: A HuGE Review , 2006 .
[53] J Fernando Bazan,et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. , 2005, Immunity.
[54] V. Álvarez,et al. Mitochondrial DNA polymorphisms and risk of Parkinson's disease in Spanish population , 2005, Journal of the Neurological Sciences.
[55] S. Jazwinski,et al. Nuclear gene expression changes due to mitochondrial dysfunction in ARPE-19 cells: implications for age-related macular degeneration. , 2005, Investigative ophthalmology & visual science.
[56] Ali H. Mokdad,et al. State of Disparities in Cardiovascular Health in the United States , 2005, Circulation.
[57] M. Fennell,et al. Targeting JNK3 for the treatment of neurodegenerative disorders. , 2004, Drug discovery today.
[58] J. Gilbert,et al. Analysis of European mitochondrial haplogroups with Alzheimer disease risk , 2004, Neuroscience Letters.
[59] I. McInnes,et al. A Novel Therapy of Murine Collagen-Induced Arthritis with Soluble T1/ST21 , 2004, The Journal of Immunology.
[60] R. Scott,et al. Mitochondrial DNA lineages of elite Ethiopian athletes. , 2004, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.
[61] J. Haines,et al. Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. , 2003, American journal of human genetics.
[62] C. Weitz,et al. Regulation of Daily Locomotor Activity and Sleep by Hypothalamic EGF Receptor Signaling , 2001, Science.
[63] M. Walport,et al. Pathogenesis of systemic lupus erythematosus (SLE) , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[64] M. Formato,et al. Urinary glycosaminoglycans in patients with systemic lupus erythematosus. , 2001, Clinical and experimental rheumatology.
[65] D. Wallace,et al. Functional Analysis of Lymphoblast and Cybrid Mitochondria Containing the 3460, 11778, or 14484 Leber's Hereditary Optic Neuropathy Mitochondrial DNA Mutation* , 2000, The Journal of Biological Chemistry.
[66] J. Montoya,et al. [Diseases of mitochondrial DNA]. , 2000, Revista de neurologia.
[67] N. Inoue,et al. Selective complement C1s deficiency caused by homozygous four-base deletion in the C1s gene , 1998, Human Genetics.
[68] G. Kahaly,et al. Glycosaminoglycans in autoimmunity. , 1996, Clinical and experimental rheumatology.
[69] D. Wallace,et al. Use of transmitochondrial cybrids to assign a complex I defect to the mitochondrial DNA-encoded NADH dehydrogenase subunit 6 gene mutation at nucleotide pair 14459 that causes Leber hereditary optic neuropathy and dystonia , 1996, Molecular and cellular biology.
[70] D. Wallace. Mitochondrial DNA mutations in diseases of energy metabolism , 1994, Journal of bioenergetics and biomembranes.
[71] C. Cepko,et al. Control of proliferation in the retina: temporal changes in responsiveness to FGF and TGF alpha. , 1992, Development.
[72] F. Sharp,et al. Epidermal growth factor and transforming growth factor α induce c‐fos gene expression in retinal muller cells in vivo , 1991, Journal of neuroscience research.
[73] G. Schultz,et al. Transforming growth factor alpha and its receptor in neural retina. , 1989, Investigative ophthalmology & visual science.
[74] L. Nanney,et al. Melanoma, growth factors, acanthosis nigricans, the sign of Leser-Trélat, and multiple acrochordons. A possible role for alpha-transforming growth factor in cutaneous paraneoplastic syndromes. , 1987, The New England journal of medicine.
[75] R. Derynck,et al. Mapping of transforming growth factor alpha gene on human chromosome 2 close to the breakpoint of the Burkitt's lymphoma t(2;8) variant translocation. , 1985, Cancer research.
[76] Lijuan Zhang,et al. Activated contact system and abnormal glycosaminoglycans in lupus and other auto- and non-autoimmune diseases. , 2010, Progress in molecular biology and translational science.
[77] P. Souich,et al. Modulation of in fl ammation by chondroitin sulfate , 2010 .
[78] R. Scott,et al. Mitochondrial haplogroups associated with elite Kenyan athlete status. , 2009, Medicine and science in sports and exercise.
[79] K. Cardarelli,et al. Racial and ethnic differences in cardiovascular disease risk factors: a systematic review. , 2007, Ethnicity & disease.
[80] N. Anderson,et al. Ethnic Differences in Dementia and Alzheimer's Disease , 2004 .
[81] A. Chomyn. Platelet-mediated transformation of human mitochondrial DNA-less cells. , 1996, Methods in Enzymology.